Health Catalyst (HCAT) CFO sells shares to cover RSU taxes
Health Catalyst (HCAT) CFO Jason Alger sold 17,973 shares at $1.7036 each to cover taxes on vesting RSUs, leaving him with 704,867 shares. The sale was mandated, not discretionary, under the company's equity plans.
How this was made
The 30-second read
Why it matters
The disclosed sale is routine and unlikely to move the stock, but it provides transparency on insider holdings.
Market read
A minor insider sell‑to‑cover transaction with negligible market impact.
What to watch
The filing confirms the CFO's continued large ownership, which could be a subtle bullish signal.
Background
Form 4 filings disclose insider transactions; sell‑to‑cover is a common tax‑withholding mechanism.
Ticker impact
CFO Jason Alger sold 17,973 shares for tax withholding on Sep 1, 2026, a mandated sell-to-cover transaction disclosed via Form 4.
Minimal short-term impact; price likely unchanged.
The transaction size (~$31K) is trivial relative to market cap and is a routine tax withholding sale, not a discretionary sell.
Market effects
No material effect on the healthcare data analytics sector.
Limited to US market; no broader regional impact.
None
Counterpoint
If the CFO holds a large post‑sale stake (704,867 shares), it may indicate confidence in long‑term prospects despite the small sell.
Key entities
- personJason Alger
Chief Financial Officer of Health Catalyst, Inc.
- companyHealth Catalyst, Inc.
Provider of data and analytics platforms for healthcare.
